Amgen Inc.
AMGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $141,006,240 | $154,090,700 | $141,300,320 | $128,232,900 |
| - Cash | $11,973,000 | $10,944,000 | $7,629,000 | $7,989,000 |
| + Debt | $60,879,000 | $64,613,000 | $38,945,000 | $33,979,000 |
| Enterprise Value | $189,912,240 | $207,759,700 | $172,616,320 | $154,222,900 |
| Revenue | $33,424,000 | $28,190,000 | $26,323,000 | $25,979,000 |
| % Growth | 18.6% | 7.1% | 1.3% | – |
| Gross Profit | $20,566,000 | $19,775,000 | $19,917,000 | $19,525,000 |
| % Margin | 61.5% | 70.1% | 75.7% | 75.2% |
| EBITDA | $13,356,000 | $14,801,000 | $12,169,000 | $11,296,000 |
| % Margin | 40% | 52.5% | 46.2% | 43.5% |
| Net Income | $4,090,000 | $6,717,000 | $6,552,000 | $5,893,000 |
| % Margin | 12.2% | 23.8% | 24.9% | 22.7% |
| EPS Diluted | 7.56 | 12.49 | 12.11 | 10.28 |
| % Growth | -39.5% | 3.1% | 17.8% | – |
| Operating Cash Flow | $11,490,000 | $8,471,000 | $9,721,000 | $9,261,000 |
| Capital Expenditures | -$1,096,000 | -$1,112,000 | -$936,000 | -$880,000 |
| Free Cash Flow | $10,394,000 | $7,359,000 | $8,785,000 | $8,381,000 |